Related Experiment Video
Updated: Mar 31, 2026
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MiR-564 functions as a tumor suppressor in human lung cancer by targeting ZIC3
Bin Yang1, Lin Jia2, Qiaojuan Guo3
1Department of Oncology, Hubei Cancer Hospital, Wuhan, Hubei 430079, China.
Abstract:
Although miR-564 was reported to be dysregulated in human malignancy, the function and mechanism of miR-564 in tumorigenesis remains unknown. In the present study, we found that miR-564 frequently downregulated in lung cancer cells and significantly inhibited cell proliferation, cell cycle progression, motility, and the tumorigenicity of lung cancer cells. Moreover, we identified zic family member 3 (ZIC3) as a direct target of miR-564. ZIC3 overexpression impaired the suppressive effects of miR-564 on the capacity of lung cancer cells for proliferation and motility. Finally, we detected the expression level of miR-564 and ZIC3 protein in tissue specimens, and found a significant negative correlation between them. Patients with low levels of miR-564 showed a poorer overall survival. Taken together, our present study revealed the tumor suppressor role of miR-564, indicating restoration of miR-564 as a potential therapeutic strategy for the treatment of lung cancer.
Insights
MicroRNA-564 (miR-564) acts as a tumor suppressor in lung cancer by inhibiting cell proliferation and motility. Its restoration presents a potential therapeutic strategy for lung cancer treatment.
Area of Science:
- Molecular Biology
- Oncology
Background:
- MicroRNA-564 (miR-564) is dysregulated in human cancers.
- The precise function of miR-564 in tumorigenesis is largely unknown.
Purpose of the Study:
- To investigate the role and mechanism of miR-564 in lung cancer.
- To identify potential therapeutic strategies for lung cancer.
Main Methods:
- Quantitative real-time PCR to assess miR-564 expression.
- Cell proliferation, cell cycle, and motility assays.
- Western blotting and luciferase reporter assays to identify miR-564 targets.
- Analysis of patient tissue specimens.
Main Results:
- miR-564 was frequently downregulated in lung cancer cells.
- miR-564 significantly inhibited lung cancer cell proliferation, cell cycle progression, motility, and tumorigenicity.
- Zic family member 3 (ZIC3) was identified as a direct target of miR-564.
- ZIC3 overexpression counteracted the tumor-suppressive effects of miR-564.
- A negative correlation between miR-564 and ZIC3 protein levels was observed in patient tissues.
- Low miR-564 levels correlated with poorer patient survival.
Conclusions:
- miR-564 functions as a tumor suppressor in lung cancer.
- The miR-564/ZIC3 axis plays a critical role in lung cancer progression.
- Restoration of miR-564 holds potential as a therapeutic strategy for lung cancer.
Related Concept Videos
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions
01:22MicroRNAs
01:22MicroRNAs
02:23Abnormal Proliferation
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...